Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New teletherapy aims to help anorexia patients find joy beyond food

NCT ID NCT05799872

Symptom relief Sponsor: Virginia Commonwealth University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This study tests a remote behavioral therapy called PAT-AN for adults recovering from anorexia. The therapy focuses on enhancing the brain's reward response to non-food experiences, like hobbies or socializing, to reduce reliance on weight-loss behaviors. Participants will receive 24 weeks of teletherapy, and researchers will track changes in BMI, eating disorder symptoms, and mood.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Positive Affect Treatment for Anorexia Nervosa (PAT-AN) - a behavioral therapy delivered via teletherapy
What this could lead to
If successful, this therapy could help people recovering from anorexia enjoy non-food-related rewards, reducing relapse risk and improving quality of life.
What could go wrong
This is an early-stage trial with only 90 participants, and the therapy is an adaptation of an existing treatment. Results may not generalize to all patients, and the remote delivery may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2023

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age \> or = 18 years old 2. Ability to read and speak in English 3. DSM-5 diagnosis of AN or atypical AN at admission to higher-level care 4. In higher-level care discharging to outpatient care or discharged to outpatient care within the past 3 months 5. Current BMI \> or = 18.5 kg/m2 (or will be by time of discharge) 6. BMI increase of \> or = 0.5 kg/m2 while in higher-level care 7. Ability to designate and sign a release of information for a primary physical or mental health provider for study duration 8. Willingness to participate in weekly assessments (e.g., weight monitoring) and audio or video recording of study therapy sessions for study duration 9. Access to a smartphone and/or computer permitting engagement in remote therapy and assessment. Exclusion Criteria: 1. Medical instability for outpatient care; 2. Pregnancy 3. Lifetime DSM-5 primary psychotic or bipolar-I disorder 4. Current DSM-5 substance use disorder 5. Enrollment in outpatient therapy with highly overlapping content to PAT-AN

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anorexia nervosa are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anorexia nervosa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anorexia nervosa

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Virginia Commonwealth University

    RECRUITING

    Richmond, Virginia, 23298, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.